Home » Stocks » scPharmaceuticals

scPharmaceuticals Inc. (SCPH)

Stock Price: $8.03 USD -0.20 (-2.43%)
Updated Jul 9, 2020 9:54 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 215.13M
Revenue (ttm) n/a
Net Income (ttm) -31.37M
Shares Out 26.79M
EPS (ttm) -1.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 9, 2020
Last Price $8.03
Previous Close $8.23
Change ($) -0.20
Change (%) -2.43%
Day's Open 8.28
Day's Range 8.01 - 8.46
Day's Volume 8,171
52-Week Range 3.40 - 11.99

More Stats

Market Cap 215.13M
Enterprise Value 159.86M
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 26.79M
Float 7.16M
EPS (basic) -1.65
EPS (diluted) -1.65
FCF / Share -1.59
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 58,324
Short Ratio 0.30
Short % of Float 0.41%
Beta 0.48
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 3.47
Revenue n/a
Operating Income -30.75M
Net Income -31.37M
Free Cash Flow -32.07M
Net Cash 55.27M
Net Cash / Share 2.06
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -24.55%
ROE -49.99%
ROIC -206.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 3
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$13.50*
(68.12% upside)
Low
10.0
Current: 8.03
High
15.0
Target: 13.50
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue-----
Operating Income-32.91-29.67-23.44-17.91-10.84
Net Income-33.00-29.44-23.82-24.38-10.52
Shares Outstanding18.6018.562.960.970.76
Earnings Per Share-1.77-1.59-8.04-25.01-13.78
Operating Cash Flow-30.44-28.81-22.68-15.46-9.64
Capital Expenditures---0.19-0.01-0.02
Free Cash Flow-30.44-28.81-22.88-15.46-9.66
Cash & Equivalents72.8189.6611839.281.57
Total Debt20.2711.3411.34--
Net Cash / Debt52.5478.3210739.281.57
Assets77.2893.7612239.771.85
Liabilities25.9215.0116.053.742.01
Book Value51.3778.74106-37.07-18.24
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name scPharmaceuticals Inc.
Country United States
Employees 15
CEO John H. Tucker

Stock Information

Ticker Symbol SCPH
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: SCPH
IPO Date November 17, 2017

Description

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.